FDA reviews NOW Health Group, Inc. facility in Bloomingdale on March 23
An inspection of NOW Health Group, Inc. in Bloomingdale was conducted by the Food and Drug Administration (FDA) on March 23 to assess protocols related to foodborne biological hazards, as shown in data on the FDA's website.
The agency’s final report stated that NOW Health Group, Inc. was not required to make any operational changes following the inspection.
The FDA routinely inspects facilities nationwide to ensure compliance with FDA-regulated laws and policies intended to protect public health, and shares inspection outcomes with the public.
As described on its website, the FDA is a federal agency tasked with overseeing the safety and quality of human and animal drugs, biological products, medical supplies and tobacco products.
Information for this article was sourced from the U.S. Food and Drug Administration. For source data, see here.